This site is intended for health professionals only

Home
>
Editor’s pick

Editor’s pick

Fosaprepitant dimeglumine is non-inferior to aprepitant

Fosaprepitant dimeglumine is non-inferior to aprepitant

Charities give £500K boost to brain tumour research at Portsmouth

Charities give £500K boost to brain tumour research at Portsmouth

Karolinska Institutet receives grant worth millions for research into regenerative medicine

Karolinska Institutet receives grant worth millions for research into regenerative medicine

Leukaemia drug faces withdrawal

Leukaemia drug faces withdrawal

Cell links discovered in research

Cell links discovered in research

NicOx: Presentation at ESH congress

NicOx: Presentation at ESH congress

FDA extends leukaemia drug use

FDA extends leukaemia drug use

Drug boost in JIA study results

Drug boost in JIA study results

Merck cancer drug trials resume

Merck cancer drug trials resume

NicOx: Presentations at EULAR congress

NicOx: Presentations at EULAR congress

Jessica Mann to leave Evolva and join Roche

Jessica Mann to leave Evolva and join Roche

FDA approves prostate cancer drug

FDA approves prostate cancer drug

« Previous 1 … 58 59 60 61 62 … 302 Next »

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x